However, it is noteworthy that obesity is a major risk factor for OA, and OA is increasingly regarded as the fifth clinical feature of metabolic syndrome, which makes the adipokine RBP4 a potential novel factor linking the metabolic state, inflammation and articular degradation in OA. This evidence concerns the gene RBP4 and obesity disorder.